aromasil has been researched along with Recrudescence in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Athanassiadis, I; Nicolatou-Galitis, O; Nikolaidi, A; Papadopoulou, E; Sonis, S | 1 |
| Kawaoka, T; Kimura, Y; Kubo, H; Miyahara, M; Nagano, H; Nagashima, Y; Shimizu, R; Yamamoto, S | 1 |
| Morohashi, H; Morohashi, S; Odagiri, H; Saito, C | 1 |
| Glück, S | 1 |
| Cartei, G; Endri, M; Fassina, A; Serino, FS; Zustovich, F | 1 |
| Bartlett, JM; Billingham, LJ; Brookes, CL; Campbell, FM; Dirix, L; Grant, M; Hasenburg, A; Hille, ET; Kay, C; Kieback, DG; Kranenbarg, EM; Mallon, EA; Markopoulos, C; Putter, H; Rea, D; Robson, T; Seynaeve, C; van de Velde, CJ | 1 |
| Bachelot, T; Baselga, J; Beck, JT; Burris, HA; Campone, M; Deleu, I; Gnant, M; Hortobagyi, GN; Ito, Y; Lebrun, F; Lebwohl, D; Mukhopadhyay, P; Noguchi, S; Perez, A; Piccart, M; Pritchard, KI; Rugo, HS; Sahmoud, T; Vittori, L; Xu, Z; Yardley, D | 1 |
| Bartlett, JM; Beck, RA; Bloom, KJ; Dirix, L; Hasenburg, A; Kieback, D; Lawton, TJ; Markopoulos, C; Piper, T; Putter, H; Rea, D; Ring, BZ; Ross, DT; Seitz, RS; Seynaeve, C; van de Velde, CJ | 1 |
| Bastiaannet, E; de Craen, AJ; Hasenburg, A; Hille, ET; Jones, SE; Liefers, GJ; Markopoulos, C; Paridaens, R; Putter, H; Rea, D; Seynaeve, C; van de Velde, CJ; van de Water, W; Westendorp, RG | 1 |
1 review(s) available for aromasil and Recrudescence
| Article | Year |
|---|---|
Exemestane as first-line therapy in postmenopausal women with recurrent or metastatic breast cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Celecoxib; Estrogens; Female; Humans; Letrozole; Middle Aged; Multicenter Studies as Topic; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Pyrazoles; Randomized Controlled Trials as Topic; Recurrence; Salvage Therapy; Sulfonamides; Tamoxifen; Triazoles | 2010 |
4 trial(s) available for aromasil and Recrudescence
| Article | Year |
|---|---|
Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial.
Topics: Androstadienes; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Europe; Female; Humans; Immunohistochemistry; Middle Aged; Patient Selection; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Recurrence; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen; Time Factors; Tissue Array Analysis; Treatment Outcome | 2011 |
Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; ErbB Receptors; Everolimus; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Postmenopause; Recurrence; Sirolimus; Stomatitis; TOR Serine-Threonine Kinases | 2012 |
Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study.
Topics: Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Immunohistochemistry; Neoplasms, Hormone-Dependent; Recurrence; Retrospective Studies; Risk Factors; Tamoxifen; Tissue Array Analysis | 2012 |
Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Postmenopause; Recurrence; Tamoxifen; Treatment Outcome | 2013 |
4 other study(ies) available for aromasil and Recrudescence
| Article | Year |
|---|---|
Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management.
Topics: Aged; Androstadienes; Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Dexamethasone; Everolimus; Female; Follow-Up Studies; Glucocorticoids; Humans; Middle Aged; Oral Ulcer; Prospective Studies; Recurrence; Sirolimus; Stomatitis; Stomatitis, Aphthous; TOR Serine-Threonine Kinases; Treatment Outcome | 2013 |
[A Case of Recurrent Breast Cancer with Bone Metastasis Successfully Treated with Everolimus and Exemestane Therapy].
Topics: Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Everolimus; Female; Humans; Middle Aged; Recurrence; Treatment Outcome | 2017 |
[A case of recurrent breast cancer with liver metastasis responding to exemestane].
Topics: Adult; Androstadienes; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Female; Humans; Liver Neoplasms; Recurrence; Tomography, X-Ray Computed | 2009 |
Differential diagnosis of lung nodules: breast cancer metastases and lung tuberculosis.
Topics: Aged; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Estrogens; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasms, Hormone-Dependent; Progesterone; Recurrence; Tamoxifen; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2010 |